2014 UK national guideline for the management of anogenital herpes (Q41345018)

29 September 2017

2014 UK national guideline for the management of anogenital herpes (English)

1 reference

29 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Raj Patel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

John Green

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Kanchana Seneviratne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Naomi Abbt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Ceri Evans

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Jane Bickford

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Marian Nicholson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Nigel O'Farrell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Simon Barton

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Mark FitzGerald

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Elizabeth Foley

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

9 April 2015

1 reference

International Journal of STD & AIDS

29 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

763-776

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Etiology of clinical proctitis among men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

The etiology of infectious proctitis in men who have sex with men differs according to HIV status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

National survey of diagnostic services for genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Oral shedding of herpes simplex virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Diagnosis of genital herpes by real time PCR in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Performance of the Focus and Kalon Enzyme-Linked Immunosorbent Assays for Antibodies to Herpes Simplex Virus Type 2 Glycoprotein G in Culture-Documented Cases of Genital Herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

An evidence based approach to testing for antibody to herpes simplex virus type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Allergic contact dermatitis from lignocaine: report of 29 cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

The natural history of recurrent herpes simplex labialis: implications for antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Safety of acyclovir in general practice: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

The Relationship between Condom Use and Herpes Simplex Virus Acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

A pooled analysis of the effect of condoms in preventing HSV-2 acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Comparative Efficacy of Famciclovir and Valacyclovir for Suppression of Recurrent Genital Herpes and Viral Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Once-daily valacyclovir to reduce the risk of transmission of genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Risk Factors for the Sexual Transmission of Genital Herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

21 January 2018

Epidemiological Synergy

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Activation of human immunodeficiency virus by herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

High cumulative incidence of genital herpes amongst HIV-1 seropositive heterosexuals in south London

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Current recommendations for the treatment of genital herpes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Treatment of resistant herpes simplex virus with continuous-infusion acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Antiviral therapy of herpes simplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Herpes simplex virus resistance to antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0956462415580512

21 January 2018

Identifiers

DOI

10.1177/0956462415580512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25861804%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference